Markets › India › BOM › EMMESSA

Emmessar Biotech & Nutrition Limited

BOM:EMMESSAHealthcare

₹21.33−2.25%At closeAt close · Tue 20 Oct · ≈ AED 0.8241 · Market cap $1.15M

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	49.5%	65.6%	60.8%	−133.9%	70.2%	−241.7%	—	—
Operating margin	11.3%	229.1%	−75.4%	−211.8%	−171.9%	−392.0%	−392.0%	+0.0 pts
Net margin	20.7%	130.3%	49.4%	135.0%	51.7%	117.6%	117.6%	+0.0 pts
EBITDA margin	12.1%	280.9%	104.2%	−194.3%	172.9%	−365.0%	—	—
Return on equity	25.4%	7.7%	7.6%	10.1%	4.1%	5.4%	5.4%	+0.0 pts
Return on assets	18.6%	6.6%	6.3%	8.6%	3.4%	4.6%	4.6%	+0.0 pts
Return on capital employed	12.3%	12.1%	−10.2%	−14.3%	−12.0%	−15.9%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—
Debt / assets	0.0%	0.0%	1.0%	1.3%	0.0%	0.0%	—	—
Interest coverage	514.0×	798.9×	−590.8×	−904.2×	−1,749.8×	−581.5×	—	—
Current ratio	3.8×	14.7×	14.1×	13.6×	15.7×	20.3×	20.3×	+0.0%
Quick ratio	3.8×	14.5×	13.8×	13.4×	15.4×	20.0×	—	—
Cash ratio	0.4×	0.6×	0.0×	0.0×	14.5×	19.0×	19.0×	+0.0%
Asset turnover	0.9×	0.1×	0.1×	0.1×	0.1×	0.0×	—	—
Inventory turnover	52.5×	1.8×	2.9×	14.6×	1.5×	13.0×	—	—
Receivables turnover	2.5×	2.7×	9.3×	1.9×	12.6×	9.1×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.